ATE502036T1 - Als inhibitoren von beta-sekretase (bace) geeignete 2-amino-3,4-dihydropyridoä3,4- düpyrimidinderivate - Google Patents
Als inhibitoren von beta-sekretase (bace) geeignete 2-amino-3,4-dihydropyridoä3,4- düpyrimidinderivateInfo
- Publication number
- ATE502036T1 ATE502036T1 AT06826564T AT06826564T ATE502036T1 AT E502036 T1 ATE502036 T1 AT E502036T1 AT 06826564 T AT06826564 T AT 06826564T AT 06826564 T AT06826564 T AT 06826564T AT E502036 T1 ATE502036 T1 AT E502036T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- bace
- secretase
- inhibitors
- amino
- Prior art date
Links
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 3
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102100021257 Beta-secretase 1 Human genes 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 101710150192 Beta-secretase 1 Proteins 0.000 abstract 2
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 abstract 2
- GZNHOSHISHLPQD-UHFFFAOYSA-N 1,4-dihydropyrido[3,4-d]pyrimidin-2-amine Chemical class N1=CC=C2CNC(N)=NC2=C1 GZNHOSHISHLPQD-UHFFFAOYSA-N 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73016505P | 2005-10-25 | 2005-10-25 | |
| PCT/US2006/041487 WO2007050612A1 (en) | 2005-10-25 | 2006-10-24 | 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE502036T1 true ATE502036T1 (de) | 2011-04-15 |
Family
ID=37744402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06826564T ATE502036T1 (de) | 2005-10-25 | 2006-10-24 | Als inhibitoren von beta-sekretase (bace) geeignete 2-amino-3,4-dihydropyridoä3,4- düpyrimidinderivate |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7531545B2 (de) |
| EP (1) | EP1966198B1 (de) |
| AT (1) | ATE502036T1 (de) |
| DE (1) | DE602006020773D1 (de) |
| ES (1) | ES2360957T3 (de) |
| PL (1) | PL1966198T3 (de) |
| PT (1) | PT1966198E (de) |
| WO (1) | WO2007050612A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US8383637B2 (en) | 2004-08-06 | 2013-02-26 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| US8426429B2 (en) | 2004-08-06 | 2013-04-23 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| US8436006B2 (en) | 2004-08-06 | 2013-05-07 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| CN101228163A (zh) | 2005-06-14 | 2008-07-23 | 先灵公司 | 天冬氨酰蛋白酶抑制剂 |
| CA2610828A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| US7868022B2 (en) | 2006-02-06 | 2011-01-11 | Janssen Pharmaceutica Nv | 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE) |
| WO2007092846A2 (en) * | 2006-02-06 | 2007-08-16 | Janssen Pharmaceutica N.V. | 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) |
| WO2007092839A2 (en) | 2006-02-06 | 2007-08-16 | Janssen Pharmaceutica N.V. | Macrocycle derivatives useful as inhibitors of beta-secretase (bace) |
| EP2032542A2 (de) | 2006-06-12 | 2009-03-11 | Schering Corporation | Heterozyklische aspartylproteasehemmer |
| EP1935420A1 (de) * | 2006-12-21 | 2008-06-25 | Merck Sante | 2-Adamantyl-Butyramid Derivate als selektive 11Beta-HSD1 Inhibitoren |
| NZ586831A (en) | 2008-01-28 | 2012-02-24 | Janssen Pharmaceutica Nv | 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
| EP2240472B1 (de) * | 2008-01-29 | 2012-11-21 | Janssen Pharmaceutica NV | Als inhibitoren von beta-sekretase (bace) geeignete 2-aminochinolinderivate |
| CL2009000954A1 (es) | 2008-04-22 | 2010-12-31 | Schering Corp | Compuestos derivados de 2-imino-3-metil pirrolo pirimidinona,inhibidores de bace-1; composicion farmaceutica; y su uso para tratar, prevenir y/o retardar el inicio de una patologia de beta-amiloide seleccionada de enfermedad de alzheimer, enfermedad de parkinson, perdida de la memoria, sindrome de down, entre otras. |
| US8394807B2 (en) * | 2008-11-20 | 2013-03-12 | Purdue Research Foundation | Quinazoline inhibitors of BACE 1 and methods of using |
| EP2504315A1 (de) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Aminoheteroarylverbindungen als beta-sekretase-modulatoren und verwendungsverfahren dafür |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761416A (en) | 1986-07-25 | 1988-08-02 | Syntex (U.S.A.) Inc. | N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds |
| US4739056A (en) | 1986-11-26 | 1988-04-19 | Syntex (U.S.A.) Inc. | N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl)oxy-alkylamides and related compounds |
| JPH0730046B2 (ja) | 1987-02-10 | 1995-04-05 | 第一製薬株式会社 | キナゾリン酢酸誘導体 |
| NZ234186A (en) | 1989-07-07 | 1991-10-25 | Janssen Pharmaceutica Nv | Imidazo quinazolin-one derivatives and pharmaceutical compositions |
| WO2001038314A1 (en) | 1999-11-23 | 2001-05-31 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| WO2002100399A1 (en) | 2001-06-12 | 2002-12-19 | Elan Pharmaceuticals, Inc. | Macrocycles useful in the treatment of alzheimer's disease |
| WO2004058686A1 (en) | 2002-04-30 | 2004-07-15 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer’s disease |
| NZ538625A (en) | 2002-09-06 | 2008-05-30 | Pharmacia & Upjohn Co Llc | 1,3-Diamino-2-hydroxypropane prodrug derivatives |
| EP1407774A1 (de) | 2002-09-10 | 2004-04-14 | LION Bioscience AG | 2-Amino-4-chinazolinone, die an den LXR Kernrezeptor binden |
| GB0325830D0 (en) | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
| RS51631B (sr) * | 2004-08-06 | 2011-08-31 | Janssen Pharmaceutica N.V. | DERIVATI 2-AMINO-KVINAZOLINA KORISNI KAO INHIBITORI β-SEKRETAZE (BACE) |
| ES2403185T3 (es) * | 2004-08-06 | 2013-05-16 | Janssen Pharmaceutica N.V. | Nuevos derivados de 2-amino-quinazolina útiles como inhibidores de ss-secretasa (BACE) |
| US8436006B2 (en) * | 2004-08-06 | 2013-05-07 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
-
2006
- 2006-10-24 AT AT06826564T patent/ATE502036T1/de active
- 2006-10-24 ES ES06826564T patent/ES2360957T3/es active Active
- 2006-10-24 PL PL06826564T patent/PL1966198T3/pl unknown
- 2006-10-24 PT PT06826564T patent/PT1966198E/pt unknown
- 2006-10-24 WO PCT/US2006/041487 patent/WO2007050612A1/en not_active Ceased
- 2006-10-24 EP EP06826564A patent/EP1966198B1/de active Active
- 2006-10-24 DE DE602006020773T patent/DE602006020773D1/de active Active
- 2006-10-25 US US11/552,792 patent/US7531545B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20070259898A1 (en) | 2007-11-08 |
| WO2007050612A1 (en) | 2007-05-03 |
| US7531545B2 (en) | 2009-05-12 |
| PL1966198T3 (pl) | 2011-07-29 |
| EP1966198A1 (de) | 2008-09-10 |
| EP1966198B1 (de) | 2011-03-16 |
| PT1966198E (pt) | 2011-05-13 |
| ES2360957T3 (es) | 2011-06-10 |
| DE602006020773D1 (de) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111086T1 (el) | Παραγωγα 2-αμινο-κιναζολινης χρησιμα ως αναστολεις της βητα-σεκρετασης (bace) | |
| WO2007092846A3 (en) | 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) | |
| DE602006020773D1 (de) | Als inhibitoren von beta-sekretase (bace) geeignete 2-amino-3,4-dihydropyridoä3,4-düpyrimidinderivate | |
| WO2007092854A3 (en) | 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) | |
| CY1111070T1 (el) | Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace) | |
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| DK1567488T3 (da) | Hydroxyethylaminderivater til behandling af Alzheimers sygdom | |
| WO2007092839A3 (en) | Macrocycle derivatives useful as inhibitors of beta-secretase (bace) | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| DK1812440T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der kan anvendes som inhibistorer af proteinkinaser | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| ATE463492T1 (de) | Kondensierte indole als dipeptidyl-peptidase- hemmer zur behandlung oder prävention von diabetes | |
| ATE396973T1 (de) | Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit | |
| EP1554256A4 (de) | Piperidinopyrimidindipeptidylpeptidaseinhibitoren zur behandlung von diabetes | |
| DE60320008D1 (de) | Heterozyklische beta-aminoverbindungen als inhibitoren des dipeptidylpeptidase zur behandlung bzw. prevention von diabetes | |
| DE602006004844D1 (de) | Pyrrolopyrimidine verwendbar als protein kinase inhibitoren | |
| DE60316416D1 (de) | Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes | |
| EP1554280A4 (de) | Antidiabetische heterocyclische beta-aminoverbindungen als inhibitoren von dipeptidylpeptidase | |
| EA200802054A1 (ru) | Ингибиторы фермента | |
| ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| BRPI0417476A (pt) | derivados de indol hidroxietilamina tricìclica e seu uso no tratamento da doença de alzheimer | |
| WO2006057945A3 (en) | 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
| WO2007058862A3 (en) | Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1966198 Country of ref document: EP |